Finance

Lists
Why is MANE down 6,88%?
Dive Deeper
MANE:NYSE
Veradermics Inc
107,15 $
-6,88%
(-7,92) 1D
16 հոկ, 12:15:52 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MANE...
Open
114,19 $
High
114,25 $
Low
107,15 $
Mkt. cap
4,48 մլրդ
Avg. vol.
843,33 հզր
Volume
232,26 հզր
52-wk high
136,72 $
52-wk low
32,00 $
EPS
-3,35 $
No. of employees
37
Open
114,19 $
High
114,25 $
Low
107,15 $
Mkt. cap
4,48 մլրդ
Avg. vol.
843,33 հզր
Volume
232,26 հզր
52-wk high
136,72 $
52-wk low
32,00 $
EPS
-3,35 $
No. of employees
37
News stories
From web sources and news partners
About Veradermics Inc
CEO-
Employees37
Founded2019
HeadquartersՆյու Հևեն, Կոնեկտիկուտ, Միացյալ Նահանգներ
Sector-
Websiteveradermics.com
Analyst ratings
Based on 4 analysts giving stock ratings to MANE in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for MANE in the last 3 months.
Highest
Current 107,15 $
182,00 $ (+69,86%)
Average
169,00 $ (+57,72%)
Lowest
160,00 $ (+49,32%)
Analyst
Recommendation
Action
Price target
Projected
Date
Geoff Meacham
Citi
Buy
Maintained
160,00 $
+49,3%
10/15/2026
Roger Song
Jefferies
Buy
Maintained
182,00 $
+69,9%
09/08/2026
Unknown Analyst
Jefferies
Buy
Maintained
182,00 $
+69,9%
09/08/2026
Serge Belanger
Needham
Buy
Maintained
164,00 $
+53,1%
08/12/2026
Rami Katkhuda
LifeSci Capital
Buy
Maintained
170,00 $
+58,7%
08/11/2026
Mayank Mamtani
B. Riley Securities
Buy
Initiated
170,00 $
+58,7%
07/15/2026
Marc Goodman
Leerink Partners
Buy
Initiated
75,00 $
-30%
03/02/2026
Prakhar Agrawal
Cantor Fitzgerald
Buy
Initiated
-
-
03/01/2026
Last report
11 օգս, 2026 թ.
Fiscal period
Q2 2026
-0,58 $ / -0,64 $
+9,56%beat
Revenue / Est. (USD)
- / 0,00
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. հնս
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
14,33 մլն
18,19 մլն
20,92 մլն
18,61 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,74 մլն
4,82 մլն
8,94 մլն
10,95 մլն
Operating expense
16,07 մլն
23,01 մլն
29,86 մլն
29,55 մլն
Total operating expenses
16,07 մլն
23,01 մլն
29,86 մլն
29,55 մլն
Operating income
-16,07 մլն
-23,01 մլն
-29,86 մլն
-29,55 մլն
Other non operating income
325,00 հզր
258,00 հզր
149,00 հզր
1,21 մլն
EBT including unusual items
-15,64 մլն
-21,85 մլն
-27,23 մլն
-23,50 մլն
EBT excluding unusual items
-15,64 մլն
-21,85 մլն
-27,23 մլն
-23,50 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-15,64 մլն
-21,85 մլն
-27,23 մլն
-23,50 մլն
Net profit margin
-
-
-
-
Earnings per share
-
-104,54
-1,32
-0,58
Interest and investment income
103,00 հզր
906,00 հզր
2,48 մլն
4,84 մլն
Interest expense
-
-
-
-
Net interest expenses
103,00 հզր
906,00 հզր
2,48 մլն
4,84 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps